Patent · US Active

Larazotide acetate compositions

US9051349B2 · kind B2 · utility

5Cited by

5References

8Claims

0Family size

Assignee

ALBA THERAPEUTICS CORPORATION · US

Inventors

Roland Callens · Grimbergen, BE
Georges Blondeel · Aalst, BE
Thierry Delplanche · Court-Saint-Etienne, BE

Key dates

Filing date	Mar 15, 2013
Grant date	Jun 9, 2015
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C53/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides crystalline forms of the peptide Gly-Gly-Val-Leu-Val-Gln-Pro-Gly (SEQ ID NO 1), and salts of the peptide, which may further have associated water molecules. These salts and hydrated salts of the peptide and compositions comprising these materials have advantageous pharmaceutical properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.